NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

406 hedge funds and large institutions have $8.86B invested in Neurocrine Biosciences in 2021 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 167 increasing their positions, 130 reducing their positions, and 54 closing their positions.

Holders
406
Holders Change
-11
Holders Change %
-2.64%
% of All Funds
7.09%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
48
Increased
167
Reduced
130
Closed
54
Calls
$83.8M
Puts
$54.6M
Net Calls
+$29.2M
Net Calls Change
+$12M

Top Buyers

1
EVM
1
Eaton Vance Management
Massachusetts
$120M
2
HM
2
HealthCor Management
New York
$38M
3
WP
3
Woodline Partners
California
$37.5M
4
Morgan Stanley
4
Morgan Stanley
New York
$34M
5
SI
5
Sofinnova Investments
California
$19.8M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$412M
2
BlackRock
2
BlackRock
New York
$987M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$489M
4
Citadel Advisors
4
Citadel Advisors
Florida
$65M
5
Capital International Investors
5
Capital International Investors
California
$109M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$987M 10,138,497 -850,977 -8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$874M 8,984,621 +155,346 +2%
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$871M 8,952,074 -279,215 -3%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$489M 5,029,259 -744,100 -13%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$412M 4,228,358 -2,873,730 -40%
State Street
6
State Street
Massachusetts
$332M 3,413,333 +145,990 +4%
BG
7
Bellevue Group
Switzerland
$294M 3,017,751 -256,800 -8%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$196M 2,015,631 +83,484 +4%
PAMU
9
Pictet Asset Management (UK)
United Kingdom
$168M 1,722,709 +160,186 +10%
DCP
10
DSM Capital Partners
Florida
$149M 1,535,484 +186,977 +14%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$141M 1,447,174 -88,637 -6%
Goldman Sachs
12
Goldman Sachs
New York
$139M 1,423,288 +15,814 +1%
Renaissance Technologies
13
Renaissance Technologies
New York
$121M 1,242,723 -155,141 -11%
EVM
14
Eaton Vance Management
Massachusetts
$120M 1,233,134 +416,718 +51%
O
15
OrbiMed
New York
$120M 1,231,115 -70,600 -5%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$117M 1,203,134 +23,626 +2%
Capital International Investors
17
Capital International Investors
California
$109M 1,116,163 -456,163 -29%
PHS
18
PFM Health Sciences
California
$109M 1,116,004 +60,494 +6%
Invesco
19
Invesco
Georgia
$106M 1,093,899 +6,534 +0.6%
RSCM
20
Rock Springs Capital Management
Maryland
$98.8M 1,015,000 – –
Franklin Resources
21
Franklin Resources
California
$93.7M 962,534 +57,680 +6%
CAM
22
Congress Asset Management
Massachusetts
$92.3M 948,565 +46,731 +5%
Northern Trust
23
Northern Trust
Illinois
$87.2M 895,859 -65,144 -7%
PA
24
Perceptive Advisors
New York
$79M 811,832 -130,000 -14%
Brown Advisory
25
Brown Advisory
Maryland
$75.7M 778,346 +13,887 +2%
1
2 3 4 5